Thermo fisher scientific completes acquisition of corevitas

Waltham, mass.--(business wire)--thermo fisher scientific inc. (nyse: tmo) (“thermo fisher”), the world leader in serving science, today announced that it has completed the acquisition of corevitas, llc (“corevitas”), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from audax private equity (“audax”), for $912.5 million in cash. thermo fisher announced the agreement to acquire corevitas on july 6, 2023. real-world evidence is the collec.
TMO Ratings Summary
TMO Quant Ranking